KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Sep 07, 2021 $1.14 $1.16 $1.10 $1.11 924 056
Sep 03, 2021 $1.15 $1.15 $1.12 $1.14 810 509
Sep 02, 2021 $1.13 $1.16 $1.11 $1.15 1 259 324
Sep 01, 2021 $1.15 $1.16 $1.11 $1.12 1 169 463
Aug 31, 2021 $1.10 $1.15 $1.09 $1.15 1 029 889
Aug 30, 2021 $1.11 $1.13 $1.08 $1.10 824 924
Aug 27, 2021 $1.06 $1.12 $1.05 $1.10 1 328 598
Aug 26, 2021 $1.08 $1.12 $1.05 $1.06 1 164 906
Aug 25, 2021 $1.09 $1.14 $1.06 $1.09 2 717 269
Aug 24, 2021 $1.05 $1.10 $1.03 $1.10 1 769 761
Aug 23, 2021 $1.05 $1.06 $1.03 $1.03 1 437 971
Aug 20, 2021 $0.98 $1.07 $0.98 $1.06 1 399 518
Aug 19, 2021 $1.02 $1.02 $0.98 $0.99 1 384 435
Aug 18, 2021 $1.02 $1.04 $1.00 $1.03 964 248
Aug 17, 2021 $1.03 $1.04 $0.99 $1.02 1 278 095
Aug 16, 2021 $1.03 $1.04 $1.00 $1.03 1 633 640
Aug 13, 2021 $1.07 $1.08 $1.02 $1.03 1 783 280
Aug 12, 2021 $1.05 $1.07 $1.04 $1.07 1 573 180
Aug 11, 2021 $1.09 $1.10 $1.02 $1.04 3 785 505
Aug 10, 2021 $1.17 $1.18 $1.07 $1.10 2 676 655
Aug 09, 2021 $1.14 $1.16 $1.12 $1.15 1 806 842
Aug 06, 2021 $1.14 $1.16 $1.09 $1.14 1 861 238
Aug 05, 2021 $1.06 $1.14 $1.05 $1.14 2 773 137
Aug 04, 2021 $1.10 $1.12 $1.05 $1.06 3 422 002
Aug 03, 2021 $1.16 $1.18 $1.11 $1.12 2 876 108
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT